Our XCART™ platform is a novel CAR T technology engineered to target patient- and tumor-specific neoantigens.
XCART PlatformOur proprietary and patented technologies are being utilized to create life-changing therapies.
Our Novel TechnologiesJan 14, 2021
Xenetic Biosciences, Inc. to Present at NobleCon17